Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

save search

Algernon Pharmaceuticals Announces Positive Feedback from U.S. FDA for Phase 1 Ifenprodil Small Cell Lung Cancer Study
Published: 2021-11-24 (Crawled : 12:00) - globenewswire.com
AGNPF | $1.58 0 twitter stocktwits trandingview |
Health Technology
| | O: 14515.38% H: 0.0% C: -1.95%

fda lung cancer phase 1 positive cancer phase 2
CEA Industries Announces Pricing of $24 Million Public Offering and Nasdaq Listing
Published: 2022-02-11 (Crawled : 02:00) - globenewswire.com
CEAD | $1.11 -0.01% -0.01% 58K twitter stocktwits trandingview |
n/a
| | O: 8900.0% H: 0.0% C: -26.67%

offering ces nasdaq
Kalera Shareholders Approve Reverse Stock Split
Published: 2022-12-23 (Crawled : 16:00) - globenewswire.com
KAL | $7.06 16.69% 34.24% 5.8M twitter stocktwits trandingview |
n/a
| | O: 7944.76% H: 0.0% C: 0.0%

kalera
Jaguar Health Announces Establishment of Board of Directors for Newly Formed Joint Venture Magdalena Biosciences
Published: 2023-01-23 (Crawled : 14:00) - jaguarhealth.gcs-web.com
JAGX | $4.71 4.2% 4.03% 970K twitter stocktwits trandingview |
Health Technology
| | O: 5426.32% H: 0.0% C: 0.0%

for health
Agile Therapeutics Announces 1-For-40 Reverse Stock Split
Published: 2022-04-26 (Crawled : 18:00) - globenewswire.com
AGRX | $0.2699 -1.86% -1.89% 790K twitter stocktwits trandingview |
Health Technology
| | O: 5161.61% H: 0.0% C: -37.31%

therapeutics
T2 Biosystems Highlights Multiple New Studies Demonstrating Improved Rapid Detection Across Several Patient Populations
Published: 2022-10-14 (Crawled : 23:00) - globenewswire.com
TTOO | $1.415 -0.35% -0.35% 220K twitter stocktwits trandingview |
Health Technology
| | O: 5078.57% H: 0.86% C: -20.0%

rapid
Diffusion Pharmaceuticals Announces 1-for-50 Reverse Stock Split as Part of Nasdaq Compliance Plan
Published: 2022-04-18 (Crawled : 14:00) - globenewswire.com
FUSN | $3.355 0.75% 0.75% 31K twitter stocktwits trandingview |
Health Technology
| | O: -1.1% H: 7.62% C: 4.46%
DFFN | $6.28 1.95% 1.91% 7.5K twitter stocktwits trandingview |
Health Technology
| | O: 4011.88% H: 0.98% C: -20.01%

nasdaq
NuZee Inc. Awarded for Innovation by World Finance
Published: 2022-12-29 (Crawled : 13:20) - prnewswire.com
NUZE | $11.49 0.61% 0.61% 29K twitter stocktwits trandingview |
Distribution Services
| | O: 3533.89% H: 0.0% C: 0.0%

for innovation
NovaBay Pharmaceuticals Chief Product Officer Dr. Audrey Kunin Returns to the QVC® Network With DERMAdoctor’s Eczema Balm
Published: 2022-11-17 (Crawled : 12:00) - biospace.com/
NBY | $2.47 -3.14% 0.0% 18K twitter stocktwits trandingview |
Health Technology
| | O: 2800.58% H: 0.4% C: -13.71%

qvc pharmaceuticals eczema
Neovasc to Report First Quarter Financial Results on May 12, 2022
Published: 2022-04-29 (Crawled : 13:20) - globenewswire.com
NVCN | $27.98 -0.14% -0.14% 36K twitter stocktwits trandingview |
Health Technology
| | O: 2289.74% H: 0.0% C: 0.0%

report results
Color Star Breaks Into The Mobile Industry with DONO Metaverse Phone
Published: 2022-09-26 (Crawled : 13:00) - prnewswire.com
CSCW | $1.2423 1.79% twitter stocktwits trandingview |
Non-Energy Minerals
| | O: 2108.96% H: 0.0% C: 0.0%

mobile metaverse star phone
Salarius Pharmaceuticals Announces Pause in New Patient Enrollment in its Phase 1/2 Trial of Seclidemstat in Ewing Sarcoma and FET-Rearranged Sarcomas
Published: 2022-10-18 (Crawled : 14:00) - biospace.com/
SLRX | $2.48 -1.98% -2.02% 34K twitter stocktwits trandingview |
Commercial Services
| | O: 2010.5% H: 0.0% C: 0.0%

pharmaceuticals seclidemstat trial
GentiBio Announces Preclinical Data Showing Antigen Specific Engineered Tregs Suppressing Pancreatic Inflammation and Potential Utility for Treatment and Prevention of Clinical Type 1 Diabetes (T1D)
Published: 2022-10-11 (Crawled : 15:20) - prnewswire.com
IBIO | $0.77 2.59% -1.69% 300K twitter stocktwits trandingview |
Health Technology
| | O: 1996.44% H: 0.0% C: -17.67%

treatment preclinical for diabetes potential pancreatic
Calithera Biosciences Announces 1-for-20 Reverse Stock Split
Published: 2022-06-14 (Crawled : 17:00) - globenewswire.com
CALA S | $0.18 0 twitter stocktwits trandingview |
Health Technology
| | O: 1912.92% H: 3.31% C: -31.39%


9 Meters Biopharma to Present at the American College of Gastroenterology (ACG) 2022 Annual Scientific Meeting
Published: 2022-10-18 (Crawled : 13:00) - biospace.com/
NMTR | $2.13 -3.62% -3.76% 76K twitter stocktwits trandingview |
Health Technology
| | O: 1894.44% H: 0.0% C: 0.0%

biopharma meeting
G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) Announces Receipt of Notice of Deficiency with Nasdaq Continued Listing Requirements
Published: 2022-11-22 (Crawled : 18:00) - globenewswire.com
GMVD | $3.81 1.6% 1.57% 110K twitter stocktwits trandingview |
Electronic Technology
| | O: 1763.64% H: 0.0% C: 0.0%

nasdaq medical
Avinger to Announce Full-Year 2021 Results on March 22
Published: 2022-03-15 (Crawled : 12:30) - biospace.com/
AVGR | $1.43 0.7% 0.7% 84K twitter stocktwits trandingview |
Health Technology
| | O: 1724.4% H: 0.0% C: 0.0%

results
AcelRx Pharmaceuticals Announces Presentation of Investigator-Initiated Trial Results
Published: 2022-10-26 (Crawled : 13:00) - biospace.com/
ACRX | $2.08 -5.46% -5.77% 110K twitter stocktwits trandingview |
Health Technology
| | O: 1705.0% H: 0.0% C: 0.0%

pharmaceuticals trial presentation results
AcelRx Pharmaceuticals Announces Reverse Stock Split
Published: 2022-10-25 (Crawled : 21:00) - prnewswire.com
ACRX | $2.08 -5.46% -5.77% 110K twitter stocktwits trandingview |
Health Technology
| | O: 1705.0% H: 0.0% C: 0.0%

pharmaceuticals
AnPac Bio Granted Continued Listing by NASDAQ Hearing Panel, Subject to Meeting $1 Bid Price Compliance Rule On or Before Nov. 23, 2022
Published: 2022-11-04 (Crawled : 12:00) - biospace.com/
ANPC | $9.24 6.45% 6.06% 23K twitter stocktwits trandingview |
Health Technology
| | O: 1696.12% H: 0.0% C: 0.0%

nasdaq meeting granted
Gainers vs Losers
62% 38%

Top 10 Gainers

Your saved searches
Save your searches and get alerts when important news are released.